Full-Time

Head of DTC Sales

Anz

Confirmed live in the last 24 hours

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

No salary listed

Senior, Expert

Sydney NSW, Australia

The role is focused on the ANZ region, indicating a potential need for candidates to be familiar with both Australia and New Zealand markets.

Category
Customer Success
Sales & Account Management
Required Skills
Business Strategy
Data Analysis
Requirements
  • Proven experience leading diverse multi-channel direct-to-consumer sales teams, ideally in the ANZ region.
  • Bachelor’s degree or tertiary qualification in Business, Marketing, or a related field.
  • Deep understanding of e-commerce platforms, omnichannel strategy, and digital marketing.
  • Strong track record of driving revenue growth and profitability in a multi-channel direct-to-consumer business.
  • Analytical mindset with the ability to interpret data, identify trends, and develop actionable insights.
  • Excellent written and verbal communication skills.
Responsibilities
  • Manage and inspire a large, high-performing sales team across multiple geographies.
  • Develop and execute a comprehensive DTC strategy for Australia and New Zealand (ANZ), focusing on revenue, profitability, and growth goals.
  • Deliver accurate sales forecasts and collaborate with the wider ANZ leadership team to assess business conditions, sales trends, and market dynamics.
  • Be accountable for achieving both top-line and bottom-line growth for the DTC business.
  • Lead digital transformation and create an omnichannel strategy that integrates physical and digital touchpoints for a seamless customer experience.
  • Leverage customer data and insights to drive decision-making and enhance the customer journey across all touchpoints.
  • Collaborate with cross-functional teams, including marketing, finance, legal, supply chain, technology, and product teams.
  • Be responsible for customer satisfaction, team engagement, contractual and regulatory compliance.
  • Establish clear performance KPIs and drive continuous improvement in customer acquisition, conversion, and retention.
Desired Qualifications
  • MBA or equivalent.
  • Proven success in managing national and/or multi country portfolios.
  • Familiarity with customer relationship management (CRM) tools and analytics platforms.
  • Previous experience in the Sleep and Respiratory Care field.

ResMed develops medical devices and software platforms that help treat and manage conditions like sleep apnea and chronic obstructive pulmonary disease (COPD). Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed serves patients, healthcare professionals, and caregivers, focusing on improving care and quality of life. Unlike many competitors, ResMed combines device sales with software subscriptions, creating a recurring revenue model. The company's goal is to reduce hospital visits and lower healthcare costs while providing effective solutions for chronic disease management.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • The wearable health tech market expansion boosts ResMed's market penetration.
  • Rising demand for COPD management solutions presents growth opportunities for ResMed.
  • Telehealth expansion enhances ResMed's cloud-connected devices and software platforms.

What critics are saying

  • Emerging digital health startups may erode ResMed's market share.
  • Rapid technological advancements require continuous R&D investment, impacting profit margins.
  • Global semiconductor shortage could disrupt ResMed's production and supply chain.

What makes Resmed unique

  • ResMed integrates AI in sleep apnea diagnosis, enhancing accuracy and efficiency.
  • The company focuses on home-based care, aligning with industry trends.
  • ResMed's cloud-connected devices offer comprehensive remote patient monitoring solutions.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

KirkpatrickPrice
May 6th, 2025
One Audit Firm, One Platform: Resmed's Journey to Settling Down

To bring consistency scalability, and simplicity to their audit engagements, Resmed partnered with KirkpatrickPrice.

GlobeNewswire
May 1st, 2025
Resmed Acquires Virtuox

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions.The acquisition reflects Resmed’s commitment to improving the way care is delivered—by making it more accessible, more coordinated, and more patient friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to support patients earlier in their journey and help healthcare providers and homecare companies deliver care in a simpler, more connected way.VirtuOx’s virtual testing platform helps reduce barriers to diagnosis, offering fast, flexible, and affordable options for patients—particularly those with sleep-disordered breathing or other conditions that are often underdiagnosed. For people suspected of having obstructive sleep apnea (OSA), a more streamlined, digital-first experience can make the difference between following through on testing and treatment—or falling out of the care pathway entirely.“This is about creating a simpler, more connected pathway to care,” said Justin Leong, Chief Product Officer at Resmed. “By integrating VirtuOx’s diagnostic capabilities into our ecosystem, we can help accelerate the time between evaluation and treatment, reduce drop-off, and help more people access the life-changing benefits of therapy for sleep apnea and related conditions.”This acquisition strengthens Resmed’s ability to partner with healthcare providers to help streamline the diagnostic process and alleviate current bottlenecks, while expanding collaboration with home medical equipment providers to efficiently and expeditiously support patients to start treatment. It further enhances the company’s ability to serve healthcare providers with integrated tools that improve care coordination, patient engagement, and outcomes.“VirtuOx and Resmed are aligned in our focus to simplify healthcare and expand access,” said Steve Lica, CEO of VirtuOx. “Joining Resmed gives us the opportunity to scale our impact, reach and help more patients, and keep innovating on behalf of the providers and health systems we serve.”The acquisition supports a growing demand for home-based care—driven by increased awareness, convenience, and digital innovation

IR Impact
Apr 24th, 2025
Resmed names Salli Schwartz as chief investor relations officer

Healthcare technology provider Resmed has named Salli Schwartz as its chief investor relations officer.

Veye
Apr 24th, 2025
Top ASX Stocks Get a Lift Post Strong Quarters

ResMed was also recognized as one of LexisNexis "Top 100 Global Innovators."

Fierce Biotech
Apr 4th, 2025
Resmed debuts wearable, at-home sleep apnea test

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.